Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway-Reference-Cited by-同舟云学术

Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway

Published:2017-02-21 Issue:14 Volume:8 Page:23436-23447
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lin Minting¹,Bi Hong²,Yan Yanyan³,Huang Wenjing¹,Zhang Guiping¹,Zhang Genshui¹,Tang Sili¹,Liu Yun¹,Zhang Lingling⁴,Ma Jinxiang⁵,Zhang Jianye¹

Affiliation:

1. School of Pharmaceutical Sciences and The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China

2. Department of Pathology, Shanxi Provincial People's Hospital, Taiyuan 030012, People's Republic of China

3. Institute of Respiratory and Occupational Diseases, Collaborative Innovation Center for Cancer, Medical College, Shanxi Datong University, Datong 037009, People's Republic of China

4. Pharmaceutical Department, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, People's Republic of China

5. School of Public Health, Guangzhou Medical University, Guangzhou 511436, People's Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer;Cancers;2024-06-12

2. Chemotherapeutics;Pharmacognosy;2024

3. Parthenolide alleviates microglia‐mediated neuroinflammation via MAPK/TRIM31/NLRP3 signaling to ameliorate cognitive disorder;International Immunopharmacology;2023-07

4. Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies;International Journal of Molecular Sciences;2023-05-23

5. The use of nanoparticles for targeted drug delivery in non-small cell lung cancer;Frontiers in Oncology;2023-03-09